These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18835219)

  • 41. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultra-endurance exercise in a heart transplant athlete: Influence on myocardial function and biomarkers.
    Esefeld K; Fricke H; Haykowsky M; Halle M
    Eur J Prev Cardiol; 2020 May; 27(8):885-887. PubMed ID: 30396292
    [No Abstract]   [Full Text] [Related]  

  • 43. Troponin I and NT-proBNP (N-terminal pro-brain natriuretic peptide) do not predict 6-month mortality in frail older patients undergoing orthopedic surgery.
    Chong CP; van Gaal WJ; Ryan JE; Burrell LM; Savige J; Lim WK
    J Am Med Dir Assoc; 2010 Jul; 11(6):415-20. PubMed ID: 20627182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer.
    Goel S; Simes RJ; Beith JM
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):276-80. PubMed ID: 21884439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple Cryotherapy Attenuates Oxi-Inflammatory Response Following Skeletal Muscle Injury.
    Zembron-Lacny A; Morawin B; Wawrzyniak-Gramacka E; Gramacki J; Jarmuzek P; Kotlega D; Ziemann E
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33120891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of serum cardiac specific biomarker release after non-cardiac thoracic surgery.
    Muley T; Kurz M; Männle C; Alekozai A; Winteroll S; Dienemann H; Schmidt W; Pfannschmidt J
    Clin Lab; 2011; 57(11-12):925-32. PubMed ID: 22239023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interface of hypothalamic-pituitary-adrenocortical axis and circulating brain natriuretic peptide in prediction of cardiopulmonary performance during physical stress.
    Popovic D; Popovic B; Plecas-Solarovic B; Pešić V; Markovic V; Stojiljkovic S; Vukcevic V; Petrovic I; Banovic M; Petrovic M; Vujisic-Tesic B; Ostojic MC; Ristic A; Damjanovic SS
    Peptides; 2013 Sep; 47():85-93. PubMed ID: 23876603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aortic augmentation index is independently associated with N-terminal pro B-type natriuretic peptide in patients with peripheral arterial disease.
    Shahin Y; Chetter I
    Vasc Endovascular Surg; 2012 Nov; 46(8):648-53. PubMed ID: 23047817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery.
    Rajagopalan S; Croal BL; Bachoo P; Hillis GS; Cuthbertson BH; Brittenden J
    J Vasc Surg; 2008 Oct; 48(4):912-7; discussion 917. PubMed ID: 18586440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and biomarker profile of trauma-induced secondary cardiac injury.
    De'Ath HD; Rourke C; Davenport R; Manson J; Renfrew I; Uppal R; Davies LC; Brohi K
    Br J Surg; 2012 Jun; 99(6):789-97. PubMed ID: 22437496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
    Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Souttar K; Elliott J
    J Vet Intern Med; 2012; 26(2):302-11. PubMed ID: 22369312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
    Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
    J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
    Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
    Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome.
    Vartany E; Imevbore M; O'Malley M; Manfredi C; Pasquarella C; Scinto L; Fine J
    J Sleep Res; 2006 Dec; 15(4):424-9. PubMed ID: 17118099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon.
    Salvagno GL; Schena F; Gelati M; Danese E; Cervellin G; Guidi GC; Lippi G
    Clin Chem Lab Med; 2014 Feb; 52(2):267-72. PubMed ID: 24088611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.